For neuropsychological testing features, we found that the Trail Making Test Parts A & B, especially Trails B, were significantly correlated with amyloid‐associated lesions, TDP‐43, Lewy body disease, and hippocampal/MTL sclerosis (Figure 2E). Here, TARDBP is linked to Lewy body dementia.